JNJ vs WST
By Alex · Tickerpine
Johnson & Johnson vs West Pharmaceutical Services, Inc., side by side — the numbers that matter, in plain English. No “winner” hype; you decide.
| Metric | JNJ | WST |
|---|---|---|
| Price | $254.66 | $350.85 |
| Market cap | $613.02B | $24.79B |
| P/E ratio | 29.5 | 47.0 |
| ROE | 26.42% | 19.13% |
| Profit margin | 21.83% | 16.85% |
| Revenue growth | 9.90% | 21.00% |
| Dividend yield | 2.10% | 0.25% |
| Beta | 0.26 | 1.18 |
Green = the more favorable figure for that metric (lower P/E, higher ROE, margin, growth and yield). Not a recommendation.
JNJ vs WST in plain English
- JNJ is the bigger company — about 24.7× the market cap of WST.
- JNJ is cheaper on earnings (P/E 29.5 vs 47.0).
- JNJ earns a higher return on equity (26% vs 19%).
- WST is growing revenue faster (21% vs 10%).
- JNJ has the higher dividend yield (2.10% vs 0.25%).
How would $1,000 have done in each?
JNJ return calculator
See what $1,000 in Johnson & Johnson would be worth today.
WST return calculator
See what $1,000 in West Pharmaceutical Services, Inc. would be worth today.
Figures from public market data, may be delayed. Comparison is informational only — not investment advice.